Search

Search Constraints

You searched for: Author/Creator Bajorin, Dean F.

Search Results

1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016. (8th December 2016)

2. A phase 2 trial of buparlisib in patients with platinum‐resistant metastatic urothelial carcinoma. Issue 20 (7th August 2020)

3. A phase II trial of durvalumab and tremelimumab in metastatic, non‐urothelial carcinoma of the urinary tract. (31st December 2020)

4. Durvalumab Plus Olaparib in Previously Untreated, Platinum-Ineligible Patients With Metastatic Urothelial Carcinoma: A Multicenter, Randomized, Phase II Trial (BAYOU). Issue 1 (1st January 2023)

5. Final Results of a Phase I Trial of WST-11 (TOOKAD Soluble) Vascular-targeted Photodynamic Therapy for Upper Tract Urothelial Carcinoma. Issue 5 (1st May 2023)

6. Four Cycles of Etoposide plus Cisplatin for Patients with Good-Risk Advanced Germ Cell Tumors. (12th March 2021)

7. Four Cycles of Etoposide plus Cisplatin for Patients with Good‐Risk Advanced Germ Cell Tumors. (12th March 2021)

8. Genomic characterization of response to chemoradiation in urothelial bladder cancer. Issue 23 (1st August 2016)

9. Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma. Issue 8 (10th March 2023)

10. Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial. Issue 12 (20th April 2022)